Summarizes the world of research into prevention of cancer. This book presents the points of relevance for oncologists and those involved professionally with prevention and screening programmes.

This book is based on presentations by some of the world's leading experts at the Sixth International Conference on Clinical Cancer Prevention, held in St. Gallen, Switzerland, during March 2010. The main themes are the latest advances in the prevention of breast and prostate cancer and the role of infection in the development of liver and gastric cancer. Special emphasis is given to perspectives on the chemoprevention of breast cancer, as the conference included an international consensus meeting on this subject. New research findings are presented and potentially more effective cancer...

More than 180 participants and experts from 31 countries met for the fifth time in 10 years in St. Gallen, Switzerland for a 3-day conference to discuss important current issues of clinical cancer prevention. The meeting was again organized and co-sponsored by St. Gallen Oncology Conferences (SONK). While SONK has been extremely successful in organizing large international c- gresses on "Primary Therapy of Early Breast Cancer" as well as "Supportive Care in Cancer" for more than 20 years, the idea of promoting interdisciplinary, clinically oriented meetings on cancer prevention is a more...

This RRCR-conference-volume marks "number six" in a 20-year evolution of international conferences on the adjuvant therapy of primary breast cancer. Starting in 1978, a handful of some 80 en- thusiastic breast cancer surgeons and oncologists, met in a se- cluded mountain resort near st. Gallen in Eastern Switzerland, to exchange their early data of some pioneer trials on adjuvant sys- temic therapy of early breast cancer, and to correlate their future research efforts to overcome the frustrating prognostic stagna- tion of this dominant neoplastic disease in Western females dur- ing the past...

The second international symposium on "Supportive Care in Cancer Patients" took place March 1-3, 1990-again in St. Gallen in eastern Switzerland. It was an honor once more to welcome dozens of internationally recognized experts in the field and more than 800 participants from over 30 countries around the world: Australia, Canada, China, USSR, USA and many countries in Europe. The international nature of the grade facilitated lively and exciting contributions and critical discussions, aimed at fostering professional knowledge and skills and rethinking our personal attitudes toward cancer...

The acquired immunodeficiency syndrome (AIDS) and the AIDS related complex (ARC) are caused by the human immunodeficien cy virus (HIV-I), previously known as human T-celllymphotropic virus type III (HTLV-III) or lymphadenopathy-associated virus (LA V). It seems that additional retroviruses (HIV-II and perhaps 1 3 others) are able to cause variants of AIDS or ARC. - Patients infected wi h the virus may (but do not necessarily) de velop a wide range of clinical symptoms that are not directly relat ed to the virus itself, but are secondary to the devastating effects of the viral infection on'...